Connect with NIDA:

Prescription Opioid Addiction Treatment Study (POATS)

Bottle knocked over with pills on the table

This was a randomized outpatient study for treatment-seeking participants dependent on prescription opioid analgesics. The primary objective was to determine whether the addition of individual drug counseling to the prescription of buprenorphine/naloxone (Bup/Nx) and Standard Medical Management (SMM) improves outcome. Participants were randomized at the beginning of each of two phases to receive BUP/NX paired with either Standard Medical Management (SMM) or Enhanced Medical Management (EMM; defined as SMM plus individual counseling). Six hundred and fifty three participants were randomized into Phase 1, and 360 participants were randomized into Phase 2.

CTN Protocol ID:

CTN-0030

DSMB ID:

DSMB-0030

Enrollment Status:

Completed

ClinicalTrials.gov ID:

NCT00316277

Primary Outcomes Article:

Weiss, et al. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence. Archives of General Psychiatry. 68(12):1238-1246.
http://www.ncbi.nlm.nih.gov/pubmed?term=22065255

Principal Investigator(s)

Roger D. Weiss, M.D.
Division of Alcohol and Drug Abuse
McLean Hospital
115 Mill Street
Belmont, MA 2478
rweiss@mclean.harvard.edu

Walter Ling, M.D.
Director
Integrated Substance Abuse Programs
University of California, Los Angeles
11075 Santa Monica Boulevard
Suite 200
Los Angeles, CA 90025
lwalter@ucla.edu

Available Brochures